HOME >> BIOLOGY >> NEWS
Pioneering research on ALS muscle disease rewarded

Leuven - Amyotrophic Lateral Sclerosis (ALS) is an incurable paralyzing neurodegenerative disorder that strikes five out of every 100,000 persons. The disease usually affects healthy people in the most active period of their lives - without warning or previous family history. Researchers from VIB (the Flanders Interuniversity Institute for Biotechnology), under the direction of Prof. Peter Carmeliet (K.U.Leuven), have been the first to demonstrate the importance of the VEGF protein in this disease. This research is opening prospects for treating ALS, and these promising results are highly appreciated by the persons concerned. The patient organization, ALS Association, has just presented 3000 of collected funds to Peter Carmeliet's team; and Diether Lambrechts and Erik Storkebaum, also members of Prof. Carmeliet's research team, have received the Galenus Prize to the value of 6200.

Incurable muscle disease

ALS can strike anyone. The Chinese leader Mao Tse Tung, the Russian composer Dimitri Sjostakowitz, the legendary New York Yankee baseball player Lou Gehrig, and astrophysicist Stephen Hawking have all been afflicted with ALS. In addition, an unusually large number of top Italian soccer players, airline pilots, and soldiers from the Golf war have been stricken by this fatal disease. About half of them die within three years - some even in the first year - usually as a consequence of asphyxiation, while still 'in full possession of their faculties'.

In a patient with ALS, the nerve bundles that run to the muscles deteriorate. The patient then loses control over his muscles, progressively becoming totally paralyzed, while remaining - disconcertingly - mentally sound. The causative mechanism of this grave, debilitating disease - which has an enormous medico-social impact - remains obscure. At present, the disease is totally untreatable. The consequence is that many ALS patients elect for euthanasia, a very controversial solution. Genetic r
'"/>

Contact: Sooike Stoops
sooike.stoops@vib.be
32-9-244-6611
VIB, Flanders Interuniversity Institute of Biotechnology
16-Jun-2005


Page: 1 2

Related biology news :

1. Pioneering research on sleeping sickness wins MERIAL Award for Parasitology
2. Pioneering approach to wastewater treatment earns Stanford engineer the 2007 Stockholm Water Prize
3. Pioneering researcher Dr. Kenneth Lyons Jones receives genetics award from March of Dimes
4. Pioneering research into health benefits of beauty treatment
5. Pioneering ecologist Ruth Patrick honored by Federal-State Commission
6. Pioneering PET/CT research widens applications of imaging for diabetic foot
7. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
8. Saudi Arabias KAUST names WHOI first research partner
9. Multinational research: protecting ecology means understanding people, too
10. Newly created cancer stem cells could aid breast cancer research
11. Carnegie Mellons Peter Adams receives EPA research grant

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
(Date:4/4/2017)... 2017   EyeLock LLC , a leader of ... States Patent and Trademark Office (USPTO) has issued U.S. ... of an iris image with a face image acquired ... company,s 45 th issued patent. ... given the multi-modal biometric capabilities that have recently come ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
Breaking Biology News(10 mins):
(Date:7/20/2017)... Reno, NV (PRWEB) , ... July 20, 2017 ... ... a real solution to make clinical trial sites and study participants truly unified. ... manage regulatory compliant (FDA 21 CFR Part 11) research studies entirely on mobile ...
(Date:7/18/2017)... ... July 18, 2017 , ... Blood centers traditionally see ... the region. Nationally, summer is a struggle for community blood centers as high schools ... San Antonio Chamber of Commerce is teaming up with the South Texas ...
(Date:7/17/2017)... (PRWEB) , ... July 17, ... ... of technology-enabled clinical trial solutions, today announced safety software company AB Cube ... the eHealth Solutions business segment to advance technology innovation across life sciences ...
(Date:7/17/2017)... ... 17, 2017 , ... DuPont Pioneer today announced the launch ... (openinnovation.pioneer.com) dedicated to connecting third-party innovators with DuPont Pioneer scientists is now available ... biologicals and digital solutions. , “DuPont Pioneer is building on its long history ...
Breaking Biology Technology:
Cached News: